June 4, 2020
The World Health Organization announced on Wednesday that it would resume trials involving hydroxychloroquine after The Lancet issued a major disclaimer over a study which prompted the WHO to halt ongoing trials, according to AFP.
“As you know, last week the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug,” said WHO Director General Dr Tedros Adhanom Ghebreyesus. “This decision was taken as a precaution while the safety data were reviewed. The Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data,” he continued.
“On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.”
— World Health Organization (WHO) (@WHO) June 3, 2020
That said, he followed the news with the not-so rosy announcement that there is “no evidence that any drug is reducing mortality of patients that have COVID-19.”
* * *
The Lancet has issued a major disclaimer regarding a study which prompted the World Health Organization to halt global trials of hydroxychloroquine (HCQ), an anti-Malaria drug currently being used around the world to treat COVID-19.
As we noted last week, major data discrepancies have called the entire study into question – though the lead author says it does not change the study’s findings that patients who received HCQ died at higher rates and experienced more cardiac complications than without.
Until the data has been audited, The Lancet issued the following “expression of concern” regarding the study.
“Important scientific questions have been raised about data reported in the paper by Mandeep Mehra et al,”reads the “expression of concern” from The Lancet.
“Although an independent audit of the provenance and validity of the data has been commissioned by the authors not affiliated with Surgisphere and is ongoing, with results expected very shortly, we are issuing an Expression of Concern to alert readers to the fact that serious scientific questions have been brought to our attention. We will update this notice as soon as we have further information.”
Of course, this is yet more evidence of the manufactured disinformation surrounding HCQ that Richard Moss, MD, (via AmericanThinker.com) exposes below…
I took hydroxychloroquine for two years. A long time ago as a visiting cancer surgeon in Asia, in Thailand, Nepal, India, and Bangladesh. From 1987 to 1990. Malaria is rife there. I took it for prophylaxis, 400 milligrams once a week for two years. Never had any trouble. It was inexpensive and effective.
I started it two weeks before and was supposed to continue it through my stay and four weeks after returning. But I stopped it after two years. I was worried about potential side effects of which there are many, as with all drugs right down to Tylenol and aspirin. These, however, are rare. At a certain point, I was prepared to take my chances with mosquitoes and plasmodium, and so I stopped.
Chloroquine, the precursor of HCQ, was invented by Bayer in 1934. Hydroxychloroquine was developed during World War II as a safer, synthetic alternative and approved for medical use in the U.S. in 1955.
The World Health Organization considers it an essential medicine, among the safest and most effective medicines, a staple of any healthcare system. In 2017, US doctors prescribed it 5 million times, the 128th most commonly prescribed drug in the country. There have been hundreds of millions of prescriptions worldwide since its inception. It is one of the cheapest and best drugs in the world and has saved millions of lives. Doctors also prescribe it for Lupus and Rheumatoid arthritis patients who may consume it for their lifetimes with few or no ill effects.
Then something happened to this wonder drug.
From savior of the multitudes, redeemer and benefactor of hundreds of millions, it transformed into something else: a purveyor of doom, despair, and unspeakable carnage.
This article was posted: Thursday, June 4, 2020 at 3:22 am